3D Printing Takes on Brain Cancer
Tel Aviv University researchers have 3D-printed a first-of-its-kind glioblastoma tumor that mimics a living cancer malignancy, powering new methods to improve treatment and accelerate the development of new drugs for the most lethal type of brain cancer.
Glioblastoma is notoriously fatal as it accounts for the majority of brain tumors and is highly aggressive. The average survival time of patients with glioblastoma is 14-15 months from diagnosis. Glioblastoma spreads quickly and in an unpredictable manner, making it particularly challenging to treat with existing approaches including surgery, radiation therapy, chemotherapy and certain targeted therapies. New drugs could drive better patient outcomes. However, existing drug development methods in the lab are time-consuming and don’t show how a treatment will work in an individual patient’s body.
To address the matter, the TAU research team created the world's first fully functioning 3D model of a glioblastoma tumor. (More)